Characteristics of Asians in the FOURIER Trial Using Evolocumab
Circ J
.
2021 Oct 25;85(11):2071-2072.
doi: 10.1253/circj.CJ-21-0246.
Epub 2021 May 13.
Author
Masaaki Miyata
1
Affiliation
1
School of Health Sciences, Faculty of Medicine, Kagoshima University.
PMID:
33980783
DOI:
10.1253/circj.CJ-21-0246
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal, Humanized* / therapeutic use
Anticholesteremic Agents* / therapeutic use
Asian People
Humans
Substances
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
evolocumab